iiinova — where your digital self keeps evolving

ILiAD Biotechnologies @iliadbio.bsky.social · 27/01/2025

We are pleased to announce that we have signed a Letter of Intent with hVIVO for a pivotal phase 3 trial of BPZE1 pertussis vaccine following an FDA meeting. www.businesswire.com/news/home/20... #whoopingcough #pertussis #biotech #vaccines #innovation

businesswire.com

ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting

ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most advanced next generation intranasal pertussis vaccine to protect against whoo

000